KR20210122621A - A system that fights new viruses and treats infected humans by applying supersaturated oxygen to the nasal passages - Google Patents
A system that fights new viruses and treats infected humans by applying supersaturated oxygen to the nasal passages Download PDFInfo
- Publication number
- KR20210122621A KR20210122621A KR1020200040427A KR20200040427A KR20210122621A KR 20210122621 A KR20210122621 A KR 20210122621A KR 1020200040427 A KR1020200040427 A KR 1020200040427A KR 20200040427 A KR20200040427 A KR 20200040427A KR 20210122621 A KR20210122621 A KR 20210122621A
- Authority
- KR
- South Korea
- Prior art keywords
- supersaturated oxygen
- human body
- fights
- viruses
- applying
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
본 발명은 과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료하는 시스템에 관한 것이다The present invention relates to a system for eradicating a novel virus and treating an infected human body by applying a supersaturated oxygen component to the nasal passages.
본 발명은 과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료 하는 시스템 으로The present invention is a system that fights new viruses and treats infected human body by applying supersaturated oxygen component to the nasal passages.
종래에는 신종바이러스에 대한 백신과 치료재가 없어 대책이없고 큰 인명피해와 경제적인 손실을 발생시키는 큰단점이 있다Conventionally, there is no vaccine or treatment material for the new virus, so there is no countermeasure, and there is a big disadvantage of causing great casualties and economic loss.
본 발명은 상기한 종래의 문제점을 해소하기 위하여The present invention in order to solve the above conventional problems
과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료 하는 시스템을 제공 하는데 목적이 있다The purpose of this is to provide a system that fights new viruses and treats infected humans by applying supersaturated oxygen ingredients to the nasal passages.
본 발명은 과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료 하는 시스템을 제공하여 목적을 달성한다The present invention achieves the object by applying a supersaturated oxygen component to the nasal passages to combat a novel virus and to provide a system for treating an infected human body.
본 발명은 과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료 하는 시스템을 제공하는 큰 장점이 있다The present invention has a great advantage in providing a system for combating a novel virus and treating an infected human body by applying a supersaturated oxygen component to the nasal passages.
도1은 본 발명의 따른,
과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료하는 시스템을 개략적으로 도시한 구조도
※ 도면의 주요 부분에 부호의 설명
1: 호흡기 인 비강 2: 코구멍의 콧털
3: 기관지 및 폐1 is according to the present invention,
Structural diagram schematically showing a system that fights new viruses and treats infected humans by applying supersaturated oxygen to the nasal passages
※ Explanation of symbols in the main parts of the drawing
1: Respiratory nasal cavity 2: Nostrils in the nostrils
3: bronchi and lungs
이하, 첨부된 도면을 참조하여 본 발명을 한정하지 않는 바람직한 실시 예를 상세히 설명한다.Hereinafter, preferred embodiments without limiting the present invention will be described in detail with reference to the accompanying drawings.
도1은 본 발명은 과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료 하는 시스템을 개략적으로 도시한 구조도이고,1 is a structural diagram schematically showing a system for fighting a novel virus and treating an infected human body by applying a supersaturated oxygen component to the nasal passages;
"구체적으로 살펴보면 아래와 같다.""If you look at it in detail, it's as follows."
본 발명은 인체를 감염시키는 신종바이러스를 멸균시키면서 감염된 인체를 치료하는 것으로써The present invention is to treat an infected human body while sterilizing a novel virus that infects the human body.
3%식용과산화수소를 중량대비20%이하 로 하고 끈적 끈적한 성질의 당류를 80%이상 혼재시켜 3%식용과산화수소의 과포화산소 성분을The supersaturated oxygen component of 3% edible hydrogen peroxide is obtained by mixing 3% edible hydrogen peroxide at 20% or less by weight and mixing more than 80% of sticky sugars.
끈적 끈적한 성질의 당류에 포집하여 대기공기에 접촉하여 쉽게 산화 되지 않도록 공기와 차단하고 멸균포장하여 제조 하고It is produced by collecting sticky sugars, blocking them from air so that they are not easily oxidized by contact with atmospheric air, and sterilized packaging.
인체의 호흡기 인 비강(1)에 바르거나 분사하여 코구멍의 콧털(2) 점막 등에 전착시켜 숨쉴 때 따라 들어오는 세균 및 바이러스를 끈적 끈적한 성질의 당류에 접착 포집시켜It is applied or sprayed to the nasal cavity (1), which is the respiratory system of the human body, and deposited on the mucous membrane of the nostrils (2).
끈적 끈적한 성질의 당류에 혼재시킨 3%식용과산화수소의 과포화산소 성분에 바이러스를 접촉 산화시켜 멸균시키는 것이고It sterilizes by contact oxidizing the virus with the supersaturated oxygen component of 3% edible hydrogen peroxide mixed with sticky sugar.
살아남은 일부 바이러스의 세력을 저하시켜 인체의 세포들이 바이러스를 용이하게 공격하여 사멸시키면서 항체를 탁월하게 발생시켜 치료하는 것을 특징으로 하는 것이다It is characterized in that it reduces the power of some surviving viruses so that the cells of the human body easily attack and kill the virus, and it is characterized by excellently generating and treating the antibody.
또한, 인체의 호흡기 인 비강(1)에 바르거나 분사하여 코구멍의 콧털(2) 점막 등에 전착시킨 본 발명의 약재를 호흡기 인 비강(1)의 점액질을 타고 기관지 및 폐(3)쪽으로 약재를 흘려보내 이동시켜 기관지 및 폐(3)쪽에 유입된 세균 및 바이러스를 멸균시켜 인체를 탁월하게 치료하는 것을 특징으로 하는In addition, the medicine of the present invention, which is applied or sprayed to the nasal cavity (1), which is the respiratory system of the human body, and electrodeposited on the mucous membrane of the nasal hairs (2) of the nose hole, rides the mucus of the nasal cavity (1), which is the respiratory system, and the medicine is directed toward the bronchi and lungs (3). It is characterized by excellent treatment of the human body by sterilizing bacteria and viruses introduced into the bronchi and lungs (3) by flowing and moving.
과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료하는 시스템 인 것이다It is a system that applies supersaturated oxygen ingredients to the nasal passages to fight new viruses and treat infected humans.
또한, 과산화수소의 과포화산소를 이용하여 유해바이러스 와 신종바이러스가 보유한 여러형태의 단백질을 산화시켜 코로나 바이러스의 스파이크단백질과 세포막융합 단계와 숙주세포합성단계 와 메신저RNA복제 전사를 방지하면서In addition, by using supersaturated oxygen of hydrogen peroxide to oxidize various types of proteins possessed by harmful viruses and novel viruses, it prevents the spike protein, cell membrane fusion step, host cell synthesis step, and messenger RNA replication transcription of coronavirus.
바이러스의 단백질기능을 억제하고 차단하여 감염된 인체를 치료하는 것을 특징으로 하는It is characterized in that it treats the infected human body by inhibiting and blocking the protein function of the virus.
과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료하는 시스템 이다It is a system that applies supersaturated oxygen to the nasal passages to fight new viruses and treats infected humans.
또한, 본 발명은 청구범위 요지를 벗어나지 않은 범위내에서In addition, the present invention is provided within the scope without departing from the scope of the claims.
어느 한 종류에 한정하지 않고 변이되며 필요용도에 따라 다종류의 항생약제 와 영양제,미네랄을 혼재하고 제조하여 기능이 추가 될 수 있다It is not limited to any one type, it is mutated, and functions can be added by mixing and manufacturing various types of antibiotics, nutrients, and minerals according to the required use.
Claims (5)
인체의 호흡기 인 비강(1)에 바르거나 분사하여 코구멍의 콧털(2) 점막 등에 전착시켜 숨쉴 때 따라 들어오는 세균 및 바이러스를 끈적 끈적한 성질의 당류에 접착 포집시켜
끈적 끈적한 성질의 당류에 혼재시킨 3%식용과산화수소의 과포화산소 성분에 바이러스를 접촉 산화시켜 멸균시키는 것을 특징으로 하는
과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료하는 시스템 ,The present invention is a system that fights new viruses and treats infected human body by applying supersaturated oxygen component to the nasal passages.
It is applied or sprayed to the nasal cavity (1), which is the respiratory system of the human body, and deposited on the mucous membrane of the nostrils (2).
It is characterized in that the virus is sterilized by contact oxidation with the supersaturated oxygen component of 3% edible hydrogen peroxide mixed with sticky sugar.
A system that fights new viruses and treats infected humans by applying supersaturated oxygen to the nasal passages.
3%식용과산화수소를 중량대비20%이하 로 하고 끈적 끈적한 성질의 당류를 80%이상 혼재시켜 3%식용과산화수소의 과포화산소 성분을
끈적 끈적한 성질의 당류에 포집하여 제조 한 것을 특징으로 하는
과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료하는 시스템 ,The method of claim 1
The supersaturated oxygen component of 3% edible hydrogen peroxide is obtained by mixing 3% edible hydrogen peroxide at 20% or less by weight and mixing more than 80% of sticky sugars.
Characterized in that it is prepared by collecting it in sticky sugar
A system that fights new viruses and treats infected humans by applying supersaturated oxygen to the nasal passages.
인체의 호흡기 인 비강(1)에 바르거나 분사하여 코구멍의 콧털(2) 점막에 전착시켜 숨쉴 때 따라 들어오는 세균 및 바이러스를 끈적 끈적한 성질의 당류에 접착 포집시켜
끈적 끈적한 성질의 당류에 혼재시킨 3%식용과산화수소의 과포화산소 성분에 바이러스를 접촉 산화시켜 멸균시키는 것을 특징으로 하는
과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료하는 시스템 ,The method of claim 1
It is applied or sprayed to the nasal cavity (1), which is the respiratory system of the human body, and deposited on the mucous membrane of the nostrils (2).
It is characterized in that the virus is sterilized by contact oxidation with the supersaturated oxygen component of 3% edible hydrogen peroxide mixed with sticky sugar.
A system that fights new viruses and treats infected humans by applying supersaturated oxygen to the nasal passages.
인체의 호흡기 인 비강(1)에 바르거나 분사하여 코구멍의 콧털(2) 점막에 전착시킨 본 발명의 약재를 호흡기 인 비강(1)의 점액질을 타고 기관지 및 폐(3)쪽으로 약재를 흘려보내 이동시켜 기관지 및 폐(3)쪽에 유입된 세균 및 바이러스를 멸균시켜 인체를 치료하는 것을 특징으로 하는
과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료하는 시스템,The method of claim 1
The medicine of the present invention, which is applied to or sprayed on the nasal cavity (1), which is the respiratory system of the human body, and electrodeposited on the mucous membrane of the nostrils (2) of the nostril, is flowed toward the bronchi and lungs (3) through the mucus of the nasal cavity (1), which is the respiratory system. Characterized in treating the human body by sterilizing bacteria and viruses introduced into the bronchi and lungs (3) by moving them
A system that fights new viruses and treats infected humans by applying supersaturated oxygen ingredients to the nasal passages,
과산화수소의 과포화산소를 이용하여 유해바이러스 와 신종바이러스가 보유한 여러형태의 단백질을 산화시켜 코로나 바이러스의 스파이크단백질과 세포막융합 단계와 숙주세포합성단계 와 메신저RNA복제 전사를 방지하면서
바이러스의 단백질기능을 억제하고 차단하여 감염된 인체를 치료하는 것을 특징으로 하는
과포화산소 성분을 비강에 도포하여 신종바이러스를 퇴치하고 감염된 인체를 치료하는 시스템,The method of claim 1
By using supersaturated oxygen of hydrogen peroxide to oxidize various types of proteins possessed by harmful viruses and novel viruses, it prevents the spike protein, cell membrane fusion step, host cell synthesis step, and messenger RNA replication transcription of coronavirus.
It is characterized in that it treats the infected human body by inhibiting and blocking the protein function of the virus.
A system that fights new viruses and treats infected humans by applying supersaturated oxygen ingredients to the nasal passages,
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200040427A KR20210122621A (en) | 2020-04-01 | 2020-04-01 | A system that fights new viruses and treats infected humans by applying supersaturated oxygen to the nasal passages |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200040427A KR20210122621A (en) | 2020-04-01 | 2020-04-01 | A system that fights new viruses and treats infected humans by applying supersaturated oxygen to the nasal passages |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20210122621A true KR20210122621A (en) | 2021-10-12 |
Family
ID=78609562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020200040427A KR20210122621A (en) | 2020-04-01 | 2020-04-01 | A system that fights new viruses and treats infected humans by applying supersaturated oxygen to the nasal passages |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20210122621A (en) |
-
2020
- 2020-04-01 KR KR1020200040427A patent/KR20210122621A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sunnen | Ozone in medicine: overview and future directions | |
| Di Paolo et al. | Ozone therapy | |
| Manjunath et al. | Recent case studies on the use of ozone to combat coronavirus: Problems and perspectives | |
| DE60239394D1 (en) | ONCOLYTIC VIRUS THERAPY | |
| ES2187798T3 (en) | PROCEDURE FOR CONSERVATION OF INFECTIOUS RECOMBINANT VIRUSES, VIRAL WATERPROOF SUSPENSION AND ITS USE AS A MEDICINAL PRODUCT. | |
| JP2016529231A (en) | A method for utilizing nitric oxide in plasma to treat medical conditions and diseases | |
| US20200281971A1 (en) | Inhibiting viral and bacterial activity using low concentration hypochlorous acid solutions | |
| Sunnen | Ozone in medicine | |
| JP2013240689A (en) | Method for taking countermeasure against floating virus infection | |
| CN111956660A (en) | Method for preventing and treating viral respiratory diseases by atomizing iodine-containing disinfectant | |
| KR20210122621A (en) | A system that fights new viruses and treats infected humans by applying supersaturated oxygen to the nasal passages | |
| Bardellini et al. | Coronavirus Disease-2019 and dental practice: A project on the use of ozonized water in the water circuit of the dental armchair | |
| KR20210121985A (en) | A system that fights new viruses and treats infected humans by applying supersaturated oxygen to the nasal passages | |
| WO2022047188A1 (en) | Process of using chlorine dioxide for the attenuation and or treatment of coronavirus diseases | |
| KR20210125875A (en) | Convergence system that sterilizes influenza virus and novel virus by applying it to the nasal cavity of the infected nose and sterilizes rhinitis bacteria | |
| Sundararajan et al. | Alternative therapies for Covid-19 | |
| KR20210123864A (en) | A system that blocks mutant viruses by applying supersaturated oxygen ingredients to the human skin | |
| US20210338715A1 (en) | Pharmaceutical composition for the treatment of covid-19 | |
| CN111265794A (en) | Atomized traditional Chinese medicine gas dust filtration virus isolation inactivation respirator | |
| Gonzalez | Iodine Oral and Nasal Rinsing: A Potential Therapeutic for COVID-19 | |
| KR20210116133A (en) | Mask system with adsorption coating of hydrogen peroxide | |
| TWI807655B (en) | An aqueous pharmaceutical composition and mobile drug delivery device for preventing and treating bacterial and viral respiratory diseases and thereof | |
| KR20210128871A (en) | Manufacture and administration system of human disinfectant that prevents the spread of virus and influenza | |
| US20220323489A1 (en) | Hypochlorous acid solutions for the treatment of drug resistant pneumonia and tuberculosis | |
| US11179415B1 (en) | Process of using chlorine dioxide for the attenuation and/or treatment of Coronavirus diseases such as COVID-19 and disabling, treating or attenuating the SARS CoV-2 virus, and its future infective variants |